“…The following cell lines were used in this study: (1) 24 breast cancer cell lines-BT-474, CAL51, DU4475, GI101, HBL100, HMT3552, Hs578T, MCF7, MDA-MB-134, MDA-MB-157, MDA-MB-175, MDA-MB-231, MDA-MB-361, MDA-MB-453, MDA-MB-468, MDA-MB-469, PMC42, SKBR3, SKBR5, SKBR7, T47D, ZR75.1, ZR75.30 and UACC3199, (2) HB4a, a cell line derived from immortalisation of normal breast luminal epithelial cells [10], (3) two non-tumourigeneic breast epithelial cell lines (MCF10A and MCF12A), (4) human mammary epithelial cells (HMECs), (5) pools of immunomagnetically sorted normal primary breast cells representing normal luminal cells [11], myoepithelial cells [11] intra-lobular fibroblasts [12] and endothelial cells [12].…”